Preview: Lexicon Pharmaceuticals's Earnings

Lexicon Pharmaceuticals LXRX is gearing up to announce its quarterly earnings on Tuesday, 2024-11-12. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Lexicon Pharmaceuticals will report an earnings per share (EPS) of $-0.16.

The announcement from Lexicon Pharmaceuticals is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.

It's worth noting for new investors that guidance can be a key determinant of stock price movements.

Earnings History Snapshot

During the last quarter, the company reported an EPS beat by $0.02, leading to a 16.09% drop in the share price on the subsequent day.

Here's a look at Lexicon Pharmaceuticals's past performance and the resulting price change:

Tracking Lexicon Pharmaceuticals's Stock Performance

Shares of Lexicon Pharmaceuticals were trading at $1.27 as of November 08. Over the last 52-week period, shares are up 11.61%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Lexicon Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.